EP3312169
5-HT3 RECEPTOR ANTAGONISTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.7.2013EP published:
15.9.2021EP application number:
17198245.7
EPO information:
European Patent Register
Max expiry date:
15.7.2033
Title:
5-HT3 RECEPTOR ANTAGONISTS
Timeline
Today
16.7.2013EP application
15.9.2021EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku Osaka-Shi, Osaka 541-0045, JP
Inventor
Name:
HITCHCOCK, StephenAddress:
San Diego, CA California 92121, US
Name:
MONENSCHEIN, HolgerAddress:
San Diego, CA California 92121, US
Name:
REICHARD, HollyAddress:
San Diego, CA California 92121, US
Name:
SUN, HuikaiAddress:
San Diego, CA California 92121, US
Name:
KIKUCHI, ShotaAddress:
San Diego, CA California 92121, US
Name:
MACKLIN, ToddAddress:
San Diego, CA California 92121, US
Name:
HOPKINS, MariaAddress:
San Diego, CA California 92121, US
Priority
Number:
201261672709 PDate:
17.7.2012Country:
US
Number:
201261708521 PDate:
1.10.2012Country:
US
Classification
Categories:
A61K 31/5386, A61P 1/04, A61P 25/06, C07D 451/12, C07D 498/08, A61K 31/19, C07D 221/22, C07D 453/02, C07D 471/04, C07D 471/08, C07D 519/00, A61P 43/00, A61P 39/00, A61P 29/00